PubRank
Search
About
Susanne B Nicholas
Author PubWeight™ 34.62
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
Nat Genet
2008
9.50
2
Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND).
Diabetes
2007
1.79
3
Coronary vasomotor abnormalities in insulin-resistant individuals.
Ann Intern Med
2004
1.65
4
Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND).
Diabetes
2007
1.61
5
Activation of vascular bone morphogenetic protein signaling in diabetes mellitus.
Circ Res
2010
1.58
6
Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
Am J Kidney Dis
2011
1.19
7
Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney.
Kidney Int
2009
1.15
8
Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis.
Mol Cancer Ther
2010
1.13
9
Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study.
Am J Nephrol
2011
1.07
10
Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy.
Nephrol Dial Transplant
2013
1.04
11
Comparison of methods for counting cells in the mouse glomerulus.
Nephron Exp Nephrol
2006
1.03
12
Diabetes mellitus and hypertension: key risk factors for kidney disease.
J Natl Med Assoc
2002
1.00
13
Estimation of glomerular podocyte number: a selection of valid methods.
J Am Soc Nephrol
2013
1.00
14
Novel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients.
Clin J Am Soc Nephrol
2011
0.90
15
Association of race/ethnicity, inflammation, and albuminuria in patients with diabetes and early chronic kidney disease.
Diabetes Care
2014
0.89
16
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
Clin Exp Nephrol
2011
0.86
17
Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations-significant evidence for linkage on chromosome 4q in African Americans: the Family Investigation of Nephropathy and Diabetes Research Group.
Diabetes Metab Res Rev
2009
0.86
18
Salutary effects of a novel oxidative stress modulator on adenine-induced chronic progressive tubulointerstitial nephropathy.
Am J Transl Res
2012
0.80
19
Insulin resistance and the endothelium.
Curr Diab Rep
2005
0.78
20
Cardiorenal metabolic syndrome in the African diaspora: rationale for including chronic kidney disease in the metabolic syndrome definition.
Ethn Dis
2009
0.78
21
Controversies in timing of dialysis initiation and the role of race and demographics.
Semin Dial
2013
0.78
22
Cyclosporin A regulates sodium-calcium exchanger (NCX1) gene expression in vitro and cardiac hypertrophy in NCX1 transgenic mice.
Ann N Y Acad Sci
2002
0.78
23
Protective cardiovascular and renal actions of vitamin D and estrogen.
Front Biosci (Schol Ed)
2013
0.78
24
Peroxisome proliferator-activated receptor-gamma in the renal mesangium.
Curr Opin Nephrol Hypertens
2002
0.78
25
Cardiac biomarkers and prediction of ESRD.
Am J Kidney Dis
2011
0.75
26
Hypertriglyceridemia and Recurrent Pancreatitis following Splenectomy.
Case Rep Gastroenterol
2007
0.75
27
The pros and cons of staging chronic kidney disease.
Ethn Dis
2010
0.75
28
Health Disparities in Kidney Transplantation for African Americans.
Am J Nephrol
2017
0.75
29
Education, motivation and medication for African Americans: bringing hypertension guidelines to practice.
Ethn Dis
2004
0.75
30
Current State and Future Trends to Optimize the Care of Chronic Kidney Disease in African Americans.
Am J Nephrol
2017
0.75
31
Racial Disparities in End-of-Life Issues in Patients with Chronic Kidney Disease.
Am J Nephrol
2016
0.75
32
Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease.
Am J Nephrol
2017
0.75